DOD Biotech Public Co., Ltd.
DOD
Rank in Stocks
#29190
DOD Biotech Public Company Limited, together with its subsidiaries,... DOD Biotech Public Company Limited, together with its subsidiaries, manufactures and distributes dietary supplements in Thailand. It offers dietary supplements for beauty and health in various forms comprising capsules, gels, jellies, powder, shot drinks, soft gels, tablets, probiotics, gummies, and direct-to-mouth. The company also provides food supplements and health drinks. In addition, it offers advisory, trading, and supplementary services; and research and development, design, FDA and HALAL registration, and consulting services. DOD Biotech Public Company Limited was incorporated in 2011 and is based in Mueang Samut Sakhon, Thailand.
Share Price
$0.01916426
Last synced: 2026-11-10
Market Cap
$8.63M
Change (1 day)
3.23%
Change (1 year)
-63.90%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade DOD Biotech Public Co., Ltd. (DOD)
Category
Consumer Defensive
Operating Margin for DOD Biotech Public Co., Ltd. (DOD)
Operating Margin as of November 2026 TTM: -2.75%
According to DOD Biotech Public Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -2.75%. At the end of 2025 the company had an operating margin of 4.45%.
Operating Margin history for DOD Biotech Public Co., Ltd. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2.75% | -161.80% |
| 2025 | 4.45% | -33.98% |
| 2024 | 6.74% | -19.67% |
| 2023 | 8.39% | -499.52% |
| 2022 | -2.10% | -107.85% |
| 2021 | 26.74% | 30.25% |
| 2020 | 20.53% | 84.79% |
| 2019 | 11.11% | -76.22% |
| 2018 | 46.72% | 24.35% |
| 2017 | 37.57% | 9.73% |
| 2016 | 34.24% | 22.94% |
| 2015 | 27.85% | -216.19% |
| 2014 | -23.97% | 0.04% |
| 2013 | -23.96% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 22.55% | -108.20% |
US
|
|
| 22.58% | -108.21% |
FR
|
|
| 18.10% | -106.58% |
GB
|
|
| 20.54% | -107.47% |
US
|
|
| 21.03% | -107.65% |
IN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about DOD Biotech Public Co., Ltd.'s operating margin
What is DOD Biotech Public Co., Ltd.'s operating margin?
DOD Biotech Public Co., Ltd.'s operating margin is -2.75%, as of Nov 2026.
What was DOD Biotech Public Co., Ltd.'s operating margin in 2025?
In 2025, DOD Biotech Public Co., Ltd.'s operating margin was 4.45%, compared with 6.74% in 2024.
How has DOD Biotech Public Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, DOD Biotech Public Co., Ltd.'s operating margin was highest in 2021 (26.74%) and lowest in 2022 (-2.10%).
How does DOD Biotech Public Co., Ltd.'s operating margin compare with similar companies?
DOD Biotech Public Co., Ltd.'s operating margin (-2.75%) is lower than that of all 5 similar companies listed above. The highest among them is L'Oréal S.A., with 22.58%.